Results 111 to 120 of about 7,978,447 (307)
Advanced Robotics Research, EarlyView.Micro‐ and nanorobots for targeted thrombolysis. This perspective elaborates on the clinical indication of blood clot disorders and current limitations for treatment. As a novel, alternative solution, micro‐ and nanorobots can be used to treat and break down thrombi.
Joshua M. Mesfin +3 more
wiley +1 more source
Rheumatology and TherapyIntroduction This work aims to describe the risk of major adverse cardiovascular events (MACE), malignancy, and mortality in real-world patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), or axial spondyloarthritis (axSpA) treated with ...
Regan Arendse +10 more
doaj +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2019 Background As reports on the influence of cigarette smoking, an important cardiovascular risk factor, on platelet ADP–P2Y12 receptor inhibitors lack consistency, we aimed to assess the effectiveness and safety of platelet ADP–P2Y12 receptor inhibitors ...
Zhiyan Liu +10 more
doaj +1 more source
, 2018 Objectives: Long-term risk of a major adverse cardiovascular events in ICU survivors who underwent acute renal replacement therapy requires further investigation. Design: Nationwide population-based study using the claims database of Korea.
Hai-Won Yoo +23 more
core +1 more source
Intelligent Micro/Nanorobots for Targeted Interventional Therapy: From Bench to Clinic
Advanced Robotics Research, EarlyView.Zirui Zhang et al. reviewed the application and challenges of mobile nanomachines in interventional therapy. By converting exogenous energy, including chemical, magnetic, optical, and ultrasonic sources, into mechanical forces, micro/nanorobots (MNRs) enable precise actuation at unprecedented scales. Evolving far beyond traditional drug delivery, these
Zirui Zhang +5 more
wiley +1 more source
, 2015 The Kaplan-Meier curves demonstrate no significant differences between statin and no-statin groups for either 12-month major adverse cardiovascular events (A, overall population; C, propensity-score matched population) or 12-month all cause mortalities ...
Seung Joon Hwang (836728) +7 more
core +1 more source
Association of periodontal disease with the risk of major adverse cardiovascular events.
, 2023 Association of periodontal disease with the risk of major adverse cardiovascular events.
Chunjuan Liao (16955321) +4 more
core +1 more source
Advanced Robotics Research, EarlyView.Flexible surgical robots are advancing minimally invasive interventions for cardiovascular diseases and cancer by enabling precise navigation through complex, submillimeter anatomical pathways. This review highlights recent innovations in actuation, bio‐integrated sensing, AI‐assisted control, and friction‐reduction technologies, discusses current ...
Hermione Truong +14 more
wiley +1 more source
Atrial Cardiopathy Worsens Neurological Severity, Raises Recurrence Rates, and Leads to Poor Vascular Outcomes in Patients With Embolic Stroke of Undetermined Source [PDF]
Journal of StrokeBackground and Purpose Atrial cardiopathy (AC) has been studied for its significance in embolic stroke of undetermined source (ESUS). This real-world study examines the relevance of AC in ESUS and its impact on stroke severity, recurrence, and major ...
Sung Hun Kim +37 more
doaj +1 more source
Advanced Science, EarlyView.Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang +6 more
wiley +1 more source